Last reviewed · How we verify
urea 40% cream
At a glance
| Generic name | urea 40% cream |
|---|---|
| Also known as | carmol 40 |
| Sponsor | Chulalongkorn University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Exploring Different Dose-frequency Home Photodynamic Therapy Protocols Using a Novel Home-targeted LED Device for Onychomycosis (NA)
- Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% (PHASE4)
- Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia (PHASE2, PHASE3)
- Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis (PHASE3)
- Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste (PHASE3)
- Sorafenib-induced Hand- Foot Skin Reaction Treatment (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- urea 40% cream CI brief — competitive landscape report
- urea 40% cream updates RSS · CI watch RSS
- Chulalongkorn University portfolio CI